Heptapeptide mimic of ohmefentanyl binding in the discontinuous μ-opiod receptor

Organic Letters

Volumn 7, Issue 14, 2005, Pages 2953-2956

  Gawley, Robert E ^a   Dukh, Mykhaylo ^a   Cardona, Claudia M ^b   Jannach, Stephan H ^b   Greathouse, Denise ^a  

^a UNIVERSITY OF ARKANSAS   (United States)

^b University of Miami   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTYLTYROSINE; DIPEPTIDE; DRUG DERIVATIVE; FENTANYL; MORPHINE; MU OPIATE RECEPTOR; PEPTIDE; TRYPTOPHYL HISTIDINE; TRYPTOPHYL-HISTIDINE;

AMINO ACID SEQUENCE; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; MOLECULAR MIMICRY; RAT;

AMINO ACID SEQUENCE; DIPEPTIDES; FENTANYL; MOLECULAR MIMICRY; MOLECULAR STRUCTURE; MORPHINE; PEPTIDES; RATS; RECEPTORS, OPIOID, MU;

EID: 22244480649     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol0509179     Document Type: Article

References (27)

1. A discontinuous binding site is one where the pertinent residues are distant in the amino acid sequence and brought into spatial proximity by protein folding. See: Eichler, J. Prot. Pept. Lett. 2004, 11, 281-290.
2. (a) de Miguel, Y. R.; Sanders, J. K. M. Curr. Opin. Chem. Biol. 1998, 2, 417-421.
3. (b) Nestler, H. P.; Liu, R. Comb. Chem. High Throughput Screening 1998, 1, 113-126.
4. (c) Nestler, H. P. Curr. Org. Chem. 2000, 4, 397-410.
5. (a) Boyce, R.; Li, G.; Nestler, H. P.; Suenaga, T.; Still, W. C. J. Am. Chem. Soc. 1994, 116, 7955-7956.
6. (b) Cheng, Y.; Suenaga, T.; Still, W. C. J. Am. Chem. Soc. 1996, 118, 1813-1814.
7. (a) Peluso, S.; Dumy, P.; Nkubana, C.; Yokokawa, Y.; Mutter, M. J. Org. Chem. 1999, 64, 7114-7120.
8. (b) Franke, R.; Doll, C.; Wray, V.; Eichler, J. Prot. Pept. Lett. 2003, 10, 531-539.
9. Monnee, M. C. F.; Brouwer, A. J.; Verbeek, L. M.; van Wageningen, A. M. A.; Liskamp, R. M. J. Bioorg. Med. Chem. Lett. 2001, 11, 1521-1525.
10. (a) Wennemers, H.; Conza, M.; Nold, M.; Krattiger, P. Chem. Eur. J. 2001, 7, 3342-3347.
11. (b) Conza, M.; Wennemers, H. J. Org. Chem. 2002, 67, 2696-2698.
12. (c) Wennemers, H.; Nold, M. C.; Conza, M. M.; Kulicke, K. J.; Neuburger, M. Chem. Eur. J. 2003, 9, 442-448.
13. (a) Chothia, C. Annu. Rev. Biochem. 1984, 53, 537-572.
14. (b) Chothia, C.; Finkelstein, A. V. Annu. Rev. Biochem. 1990, 59, 1007-1039.
15. (c) Finkelstein, A. V.; Ptitsyn, O. Prog. Biophys. Mol. Biol. 1987, 50, 171-190.
16. (d) Loughlin, W. A.; Tyndall, J. D. A.; Glenn, M. P.; Fairlie, D. P. Chem. Rev. 2004, 104, 6085-6118.
17. (e) Gillespie, P.; Cicariello, J.; Olson, G. L. Biopolymers 1997, 43, 191-217.
18. (f) Smith, C. K.; Regan, L. Acc. Chem. Res. 1997, 30, 153-161.
19. (a) Tang, Y.; Chen, K. X.; Jiang, H. L.; Wang, Z. X.; Ji, R. Y.; Chi, Z. Q. Acta Pharmacol. Sinica 1996, 17, 156-160.
20. (b) Xu, H.; Lu, Y.-F.; Partilla, J. S.; Zheng, Q.-X.; Wang, J.-B.; Brine, G. A.; Carroll, F. I.; Rice, K. C.; Chen, K.-X.; Chi, Z.-Q.; Rothman, R. B. Synapse 1999, 32, 23-28.
21. Brine, G. A.; Stark, P. A.; Liu, Y.; Carroll, F. I.; Singh, P.; Xu, H.; Rothman, R. B. J. Med. Chem. 1995, 38, 1547-1557.
22. Subramanian, G.; Paterlini, M. G.; Portoghese, P. S.; Ferguson, D. M. J. Med. Chem. 2000, 43, 381-391.
23. (a) Copeland, G. T.; Jarvo, E. R.; Miller, S. J. J. Org. Chem. 1998, 63, 6784-6785.
24. (b) Miller, S. J.; Copeland, G. T.; Papaioannou, N.; Horstmann, T. E.; Ruel, E. M. J. Am. Chem. Soc. 1998, 120, 1629-1630.
25. (c) Copeland, G. T.; Miller, S. J. J. Am. Chem. Soc. 1999, 121, 4306-4307.
26. Wennemers, H.; Still, W. C. Tetrahedron Lett. 1994, 35, 6413-6416.
27. Connors, K. A. In Binding Constants: The Measurement of Molecular Complex Stability; Wiley-Interscience: New York, 1987; pp 339-343.